BackTaysha Gene Therapies Overview
Taysha Gene Therapies Inc

Taysha Gene Therapies Target Price

Where could TSHA trade next? Consensus target price: $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.99

Average Target Price

$14.00180.6% upside

3 analysts in the last 4 months

High: $15 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-21Goldman Sachs$13160.5% upsideOpen
2026-06-30Robert W. Baird$15200.6% upsideOpen
2026-06-23Pivotal ResearchKeith Tapper$14180.6% upsideOpen
2026-01-06Raymond JamesChris Raymond$13160.5% upsideOpen
2026-01-05Wells FargoZachary Fadem$11120.4% upsideOpen
2025-12-04Goldman Sachs$11120.4% upsideOpen
2025-12-04UBS$11120.4% upsideOpen
2025-11-14Cantor FitzgeraldKristen Kluska$13160.5% upsideOpen
2025-11-05JMP Securities$860.3% upsideOpen
2025-10-02Robert W. BairdJack Allen$12140.5% upsideOpen
2025-10-02NeedhamGil Blum$10100.4% upsideOpen
2024-08-14BMO CapitalKeith Tapper$50.2% upsideOpen
2024-07-01Piper SandlerChristopher Raymond$740.3% upsideOpen
2024-05-14JefferiesEun Yang$860.3% upsideOpen
2024-04-09Raymond JamesChristopher Raymond$980.4% upsideOpen
2023-02-01Jefferies$1.569.9% downsideOpen
2021-10-19Morgan StanleyMatthew Harrison$39681.6% upsideOpen
2021-05-19Cantor FitzgeraldKristen Kluska$44781.8% upsideOpen

Taysha Gene Therapies (TSHA) FAQ

The latest target price for TSHA is $14. Investors often review this figure alongside Taysha Gene Therapies's historical trend and sector peers before judging valuation or financial health.

Taysha Gene Therapies trades near $4.99 while the consensus target sits at $14 (180.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting TSHA's target price ($14), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Taysha Gene Therapies's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.